Ad
related to: lonza usa inc
Search results
Results From The WOW.Com Content Network
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.
January 2, 2024 at 2:03 AM. PORTSMOUTH — Work has begun on the construction of a major new warehouse and distribution facility at Pease International Tradeport. Developers Procon Inc. and The ...
Moderna expects to absorb the demand currently supported by Lonza at its internal manufacturing site at Norwood in Massachusetts for 2024-25, the company said. Moderna to cut mRNA drug substance ...
BMO USA: Chicago, Illinois: $295 7.9 $68.12 BMO 16 American Express: New York City: $269 7.0 $136.52 AXP 17 HSBC Bank USA: New York City: $246 10.9 $155.81 HSBC 18 Citizens Financial Group: Providence, Rhode Island: $220 7.9 $15.45 CFG 19 First Citizens BancShares: Raleigh, North Carolina: $217 – $20.47 FCNCA 20 USAA: San Antonio, Texas: $217 ...
US$750 million (2011) [2] Number of employees. 3,600 (2016) [1] Parent. Lonza Group. Website. capsugel .com. Capsugel is a company that manufactures and sells two-piece hard gelatin drug capsules. [3] : 703 Capsugel also sells equipment for filling empty and liquid capsules, as well as equipment for sealing liquid capsules.
Lonza said on Tuesday it has capacity to fill syringes to serve makers of highly popular new weight-loss drugs in a class known as GLP-1, though it does not produce the active ingredient in those ...
Catalent, Inc. ( Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, [2] including approximately 2,400 scientists and technicians.
Lonza Group Ag (LZAGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Ad
related to: lonza usa inc